news.yahoo.com

news.yahoo.com
Share

news.yahoo.com

 •  February 14

LONDON (Reuters) - A clinical trial of an experimental vaccine against the deadly Ebola virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with U.S. scientists. The world's worst outbreak of Ebola has killed nearly 1,000 people in West Africa and the disease could continue spreading for...

news.yahoo.com

 •  February 14

(Reuters) - Chemotherapy as a treatment for advanced melanoma could soon become obsolete, researchers said on Sunday, after patients taking an experimental immuno-oncology drug from Bristol-Myers Squibb Co had a much higher survival rate and had other favorable results. The impressive results, compared with chemo, were seen in a late-stage study of...

news.yahoo.com

 •  February 14

More ZURICH (Reuters) - Swiss pharma group Novartis AG said on Monday it would work with Bristol-Myers Squibb Co to test the U.S. drugmaker's immuno-oncology drug Opdivo in combination with three of its own experimental lung cancer drugs. The clinical collaboration will help Novartis advance its efforts in the field of immunotherapy, one of the...

news.yahoo.com

 •  February 14

(Reuters) - Drug developer Auspex Pharmaceuticals Inc said its drug for treating chorea, or involuntary movement associated with Huntington's disease, met the main goal in a late-stage study. Auspex shares were up about 64 pct in after-hours trading. Patients administered SD-809, Auspex's lead drug, showed an improvement in a standardized score...

news.yahoo.com

 •  February 14

More WINNIPEG Manitoba (Reuters) - Canada will donate a small quantity of an experimental Ebola vaccine developed in its government lab to the World Health Organization for use in Africa, the country's health minister said on Tuesday. The decision to donate the vaccine came after the WHO said on Tuesday that it was ethical to offer untested drugs...

news.yahoo.com

 •  February 14

More Geneva (AFP) - Swiss-based pharmaceuticals giant Novartis said Wednesday that it had signed a licensing deal with an international organisation that fights tuberculosis. In a statement, the group said that the exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development covered compounds discovered at the Novartis...

news.yahoo.com

 •  February 14

View photosMore Paris (AFP) - Parasites resistant to the frontline malaria drug have spread westward from southeast Asia to just short of the Indian border -- a gateway to Africa, researchers warned Friday. A spread into India "would pose a serious threat to the global control and eradication of malaria," said a statement that accompanied the study...

news.yahoo.com

 •  February 14

More (Reuters) - South Carolina's Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks. A trial court had earlier ordered J&J to pay $327 million, but the Supreme Court more than halved...

news.yahoo.com

 •  February 14

More LONDON (Reuters) - An experimental shingles vaccine from GlaxoSmithKline has produced impressive results in a late-stage study, giving the group's expanding vaccine unit a potential $1 billion boost. The data suggests the British company's new shot could be a strong competitor for Merck & Co's established vaccine Zostavax, which is currently...

news.yahoo.com

 •  February 14

More LONDON (Reuters) - AstraZeneca's blood-thinning drug Brilinta cut the risk of death or heart attack in patients with a history of previous attacks, according to a major clinical trial that will boost hopes for the closely watched product. Giving Brilinta to patients who had a heart attack over a year ago could more than double the number of...